Associated Papers
BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population.
Bhatt D et al.
Journal of Oncology, 2021
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.
Lehnerdt GF et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2009
Select a paper to view details